Therapeutic Efficacy and Safety of Non-Invasive RF Treatment in Refractory MGD — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Therapeutic Efficacy and Safety of Non-Invasive RF Treatment in Refractory MGD — Stella

Recruiting

Back to Dry Eye Syndromes trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(2 sites)

Hong Kong

Grantham Hospital, Hong Kong

HKU Eye Centre, Hong Kong

Key details

Sponsor

The University of Hong Kong

Enrollment target

~112 participants

Started

October 2024

Primary completion

October 2027

Age range

18 Years and older

Last updated December 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov